Data / Form D filings / Perle Bioscience, Inc.
Perle Bioscience, Inc.: Form D filings
Perle Bioscience, Inc., a company in Charleston, SC, filed 5 Form D notices with the SEC between 2014 and 2015. The latest, on December 30, 2015, reports $1.8 million sold of a $2.8 million offering to 4 investors.
Find out what Perle Bioscience, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 520 FOLLY ROAD, SUITE P212, Charleston, SC, 29412
- Phone
- (843) 568-2603
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1605829
The full lists. Form D filings in South Carolina: 341 rows, $17.05, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2015 | Amendment | $2,750,000 | $1,798,500 | $951,500 | 4 | Nov 24, 2015 | sec.gov |
| Dec 7, 2015 | New notice | $2,750,000 | $1,729,993 | $1,020,007 | 2 | Nov 24, 2015 | sec.gov |
| Jul 28, 2014 | Amendment | $3,300,000 | $2,934,739 | $365,261 | 14 | Apr 17, 2014 | sec.gov |
| Jun 25, 2014 | Amendment | $3,300,000 | $2,909,238 | $390,762 | 13 | Apr 17, 2014 | sec.gov |
| Apr 29, 2014 | New notice | $3,300,000 | $464,501 | $2,835,499 | 4 | Apr 17, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey N. Riley | Director | |
| Douglas N. Carnes | Director | |
| Donna N. Hill | Director | |
| Claresa N. Levetan | Executive Officer, Director | |
| Ryan N. Fiorini | Executive Officer, Director | |
| Gilbert N. Nathan | Director |
Other companies in South Carolina that filed recently
- OZPros QOF, LLC $2.9 million · Oct 26, 2026
- Accountally LLC $750,000 · Oct 16, 2026
- Velori Holdings, LLC $200,000 · Oct 15, 2026
- Plot Picks Inc. $50,000 · Oct 8, 2026
- Cardinal Club, LLC offering · Oct 5, 2026
- FLI Twin Oaks Holdings, LLC offering · Sep 21, 2026
Every Form D from the week of Dec 28, 2015 · All recent filings in South Carolina · All recent Other filings
Read from SEC EDGAR. Amount sold is what Perle Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.